麻花传MV在线观看的最新进展,狠狠躁日日躁夜夜躁2022麻豆,亚洲WWW啪成人一区二区麻豆,人妻夜夜爽天天爽三区麻豆AV网站,麻豆成人精品国产免费,国产成人精品三级麻豆,麻豆美女裸体AAAA片,麻豆 美女 丝袜 人妻 中文,国产麻豆剧传媒精品国产AV,无码人妻aⅴ一区二区三区麻豆,狠狠色丁香婷婷久久综合麻豆

NEWS
ANFIDA
Check category

Policy innovation breaks thδ♥e bottleneck, proactively str¶≈✘ikes out to find a new life-the joi‍&♥nt dynamic cartilage regeneratγ>‌ion project ushered i∑>‌n new opportunities for develop§§∑₹ment

  • Categories:Industry News
  • Author:
  • Origin:
  • Time of issue:2020-04-08 11:12
  • Views:

(Summary description)April 21, Tianjin Northne£'™↕t News: After more th♦®an half a year of demonstratβ‍ion in the Tianjin Pilot Free Trσ¶ade Zone, the "Report on∏÷< the Pilot Test of Cell Therapy in the®'© Tianjin Pilot Free Tra ¥×de Zone" was drafted an‌ d then submitted to the Minis←≈✔¶try of Commerce of t™♠he People’s Republic o≈σ™f China, and the Municipal Health <σε×The health, drug supervision, a←♣nd technology departments jointly or✔®πganize industry regulator¥©y organizations to promoteΩ★ the admission of low- and medium-♦λrisk cell therapy products ♥∑with medical technology and carry©→∏ out clinical applications.≥ε Patients with related diseases can di&≥>≤rectly enjoy cell diagn$↑osis and treatment in the Tianjin Pi₽÷lot Free Trade Zone and the Joint Inn♣$≈λovation Zone. Scientific researcφ↑h institutions and cell tech™λnology-related companies can ★©also let go of research and realize ±₹clinical translational applications m↔πφore quickly. Joint Power Biotechno∞§logy Co., Ltd., a subsidiar" y of Tianjin Anda Group, firmly sei'↔γzed the opportunity to<£§✘ focus on the world's ∞©βleading technology in the regenera©>≈tion and repair of a↓α♠utologous cartilage cells. The Distri‌≈ct Bureau of Science'∑β← and Industry established contacts, '•αintroduced the company λ₽9;s development history, prov♥σided detailed technical mate•<rials for the project, and invited<±♥λ them to the company forγ✔™ inspection and guidπσance.

Policy innovation breaks €§≤£the bottleneck, proactively strikes o≠↓ut to find a new life-t©♦αhe joint dynamic cart♥∑₩×ilage regeneration projec©→→®t ushered in new opportunities for ↓₽development

(Summary description)April 21, Tianjin Nor​↕∏ thnet News: After more than half α$∏a year of demonstration in thε™e Tianjin Pilot Free Trade♣φ Zone, the "Report on the Pilot T✔♦♥est of Cell Therapy in t★ ®he Tianjin Pilot Free T ↕∑&rade Zone" was draf£​γted and then submitted to the Ministryγ♥¥↑ of Commerce of the People’♦×Ωαs Republic of China, and the Mu± δnicipal Health The health>$₽, drug supervision, and techn≠€εology departments jointly organiz✘✘✘αe industry regulatory↑™ organizations to pr∏¶'omote the admission of lo$™↕w- and medium-risk celλ≠l therapy products with ₽≈₩ medical technology and &✔↕carry out clinical ap∞♣plications. Patients≥λ© with related diseases can directl✔✘ y enjoy cell diagnosis £↓↑ and treatment in the Tianjin ₽γ♦≠Pilot Free Trade Zone and the Joi ★≥nt Innovation Zone. Scientific r÷&•©esearch institutions and ce ←ll technology-related compaγ≤<€nies can also let go of←&™ research and realize clini¶'cal translational applications mo♥≤π<re quickly.

Joint Power Biotechnolo&¶gy Co., Ltd., a subsidiary o♥αf Tianjin Anda Group, firmly seized ×>the opportunity to focu↔ s on the world's leading technolog≈¶y in the regeneration and repair ₩‍≠$of autologous cartilage cells. The Dis​₩←trict Bureau of Science and σ≤≤Industry established contacts,☆♠£✘ introduced the company★•♥ε's development <£$history, provided detailed technical ‍σβ↔materials for the proj≈±ect, and invited them to the <÷¥company for inspection and guidanceα'.

  • Categories:Industry News
  • Author:
  • Origin:
  • Time of issue:2020-04-08 11:12
  • Views:
Information
April 21, Tianjin North↓£ net News: After more t♠ αλhan half a year of demon↔✔÷βstration in the Tianjin Pα↑♦Ωilot Free Trade Zone, the "Report§δ>® on the Pilot Test of Cell The££rapy in the Tianjin Pilot Free Trad<εe Zone" was draf☆δ₩ted and then submitted to the M☆✔±inistry of Commerce of the People&rsq‌< ≠uo;s Republic of China, and the•←γ± Municipal Health The↔φ↕ health, drug supervision, φ<∞and technology departments jointly o↑✔♣♣rganize industry regulat₽♦'ory organizations to promote the a™σ≥"dmission of low- and medium-risk cell©☆±> therapy products with medical te∏'chnology and carry out clinical"≠<₽ applications. Patients wi←₹th related diseases can dir↑÷δectly enjoy cell diagno¥₹÷∞sis and treatment in€∞ the Tianjin Pilot Fr→₽↓♥ee Trade Zone and the Joint Inn✘↓∞ovation Zone. Scientific re>$∞search institutions §↕and cell technology-relate↑•d companies can also let‌☆ go of research and re∑ββalize clinical translational applicati≠α↔♣ons more quickly.
 
Joint Power Biotechnoloπ φ gy Co., Ltd., a subsidiary★≤ of Tianjin Anda Group, firmly seiz↓ ed the opportunity to focus on the worוld's leading technology↑ £© in the regeneration and repair of a∏©σutologous cartilage cells. The Distr‍β✔ict Bureau of Science aσ♦₹nd Industry establishΩ &λed contacts, introduced the companα&y's development his≠←tory, provided detailed technical ☆₩materials for the project, and inv ↓ ited them to the company¶≤ for inspection and guida"∑≠×nce.

  On May 12th, Chen Mingye,ε<¥$ director of the Polic✔'↑y Research Office of the Binhai↔♦↔  New Area Innovation and Development Bu↑ reau, led Wang Jing, the sen←§φ‍ior director of biotechnolog↓×y projects, to Joint Power Biotechα$>₽nology Co., Ltd. and discussed the ca₽ rtilage regeneration project wit§→÷‌h Yuan Jizu, General Manager of Anda©σ Group, and Chen Ming, General σ←✘Manager of Joint Power Through discuss✘≈ions and discussions​ →♠, a preliminary consensus was reach£♠ed on efforts to include ☆↔₩the cartilage regeneration pro→♦↔ject in the pilot promotion pl§ σan of cell therapy in the free trade ♥©zone, and the opinions on ar​&ranging for district leaders t∞₹∑o be invited to visit were put↕™÷¥ forward.

 
Led by the Innovation Bureau, it ±"​‌will conduct a comprehe♣←nsive evaluation of the projec₩εt in conjunction with the Health'♠σ♦ and Health Commission, th‌φ•e Food and Drug Admin€♦istration, and related hospiπ¥¥ tals, and integrate application<¶σ scenarios as soon as ∏λ&$possible to break throu>✔>≤gh the bottleneck of corporate§‍₽∏ development with policy innovation.

On June 10th, full-time φ deputy director of the China (γβ>Tianjin) Pilot Free Trade Zone ​"Management Committee, deputy head o✘≥λ≈f Tianjin Binhai New Area People&rsq✘¥‍®uo;s Government and directo‍≠ r of Binhai New Area Innovation and De♣§velopment Bureau Yin Xiaofeng, led by D​∑"eputy Director of Innov∏™ation and Development B→♦ureau Zhou Minhua, free trade zone♥→≠ airport area He Jiang, director of th<€✔∑e work bureau, and sta¶×ff from related departme↓Ω‌★nts came to Joint Power. They first →♥γvisited the purification w‍δ¶orkshop and learned abou₹γεt the production process, and ±​ then had a long discusγα÷sion in the conference room. Group Genσ£eral Manager Yuan Jizu fi•$'rst expressed welcome and thanks to D£↑irector Yin Xiaofeng and his deleg δ∑ation on behalf of Chairman Cui Ho←εngjin, and introduced the ovβ​ ∏erall situation of the ↓★≈ group. Chen Ming, general manager oγ☆≈f Joint Power, elaborated on the•$ company's development history, ¶♠↕technological leadership, safety £"<₩and effectiveness, possible economic ∑§and social benefits, difficultie‌∏s encountered before, an↔≠d urgent problems to be solve★ d, and answered everyone one '" ±by one. Question. Deputy Dis>∑$trict Chief Yin Xiaofeng fully®±¶→ recognized the cartilage rege↕ε∏neration technology. Afte¥≠♣r analyzing the diff¶αiculties encountered by the company,×≈≥♥ he put forward specific solutions. He ₽↕said: The joint dynamics technology is '↕a good technology that benefits the©φ≤Ω people and can effectively solve the  ÷✘common people. The pain caused βδ÷by osteoarthritis, but due t✔Ω≤o the lack of policy guidance, it →★•has not been fully promoted. This &ε time, it is necessary to breπ∏ak through the bottleneck through p ↓‌εolicy innovation, system i♥←♥nnovation, and pioneering t₹♣rials. The core problem o  ¶f cell therapy is ap≠♠plication, and only find a∑ pplications Only when cl₽£ε™inical experts approve and apply the sc δ∏enarios can the real •≠value be realized. Iλ₩♥‍n the next step, we must work hard​♥ to find clinical application sc∑₹ enarios for enterprises, a 'nd organize and coordinate  →relevant departments to do a goo₽£d job of docking serv↑™♥φices. According to the suggestion p<∞πut forward by the Deputy Distri≠≈§₩ct Mayor Yin Xiaofeng,₩ ♣ Joint Power Company coopera✘™σted with relevant depar$¶‍∞tments to make a detailed plan to carr₹↑φy out docking work with three cliπ★ λnical hospitals in the fr©✔λee trade zone, and s≠∏trive to realize cli®₩nical application as sφ<oon as possible. Wang Junpeng, α₹≥assistant to the chaφ®irman of the group, also atten÷π←ded the meeting.

On June 11, the Binhai New Area In ‌>novation Development Bureau, Joint Powε©↕er Company, and Tianjin Medical Uε∞♦niversity General Hospital joσβ​intly held a symposium to₽δ∞ discuss the clinica↕≥l application of cartilage regeneε₽ration technology. Chen Mingye, Direδ☆♠ctor of the Policy Research Office o§✘f the Innovation Bureau, Wang Jiφ≈‌‍ng, Senior Director, a♣↑nd Deputy General Hos"  pital Li Hui, Dean and Direct&★β or of Orthopedics Center, Zh☆®♠ang Yuan, Director of T∏↓rauma Surgery of Ort®£★hopedics Center, Zhang Huafeng, De>βδ∞puty Director of Joint Surgery₩α'ε, Li Zhijun, attending × λphysician of Joint Surg↓ <ery and postdoctoral fellow of Stanfor£®★d University, and Chen Ming,→± General Manager of Join$≤∑αt Power Company attended •γthe event. The meeting was presid <ed over by Chen Mingye,α§ Director of the Office of In≠↕novation Bureau. He first introduc↕♦↓¥ed the theme of the meeting and "±λthe overall plan of the B'Ω&✔inhai New Area Innovation Bur< ★eau for the clinical access po↕£ ®licy of cell therapy. Hσ₹e gave high praise to Joint Power Compa♥→σny’s cartilage cell regen♠≈eration technology, and he pla​≠♣•nned to serve as the ↕​first Three pilot projects in the free ×±π•trade zone will be clinically promoted‌§.
General Manager Chen Ming int←₩$‌roduced the developme $nt process and advantages of ≤β CaRes technology in detaγ•il, and shared the cli≤"Ω↓nical cases done over the yea•±rs with clinical experts present. Durδλing the period, Vice President Li Hui a☆↔nd his orthopedic tea✔♦✘m members listened carefully ≤•♠βand communicated in depth, and ↓∑®<everyone agreed. It is believed↕γγσ that CaRes is a safe aπ‌"αnd effective clinical technology fo↓$∏r the treatment of cart‌§ilage injury, which i®¥s worthy of clinical promotio₩→≈n, and it is proposed th↑ε₽§at the technology has be¥σ↕"en available for more✔π than ten years. Starting wi"​¥th cell viability and improviσ✔÷ng surgical methods, the original open₹​  surgery is upgraded to minimally i‌'nvasive surgery, which grea♦™tly reduces the trauma of pati↔σents and improves the eff'&φiciency of surgery. This"•€ technology has become the γ only standardized clinical practice ♠ ↔≥in China that patient✘δεs are willing to accepβ±​t and are clinically convenient↕↔. technology.
Director Chen Mingye po÷'€φinted out in the final s÷♠ummary that this meeti§​ng truly embodies the‍₹ positioning of the Frβγ$ ee Trade Zone Innovation Bureau foσ→★εr the clinical access p'>→olicy of cell therapy¶¥α technology. We will continue to foll±π↑ow up on this project, provide all ÷¥'guarantees, and escort Jo∞☆÷÷int Power Company's carti¥←lage regeneration te•↕λchnology to achieve full clinical©↑ access as soon as p™>±Ωossible, to achieve econ≤∏omic benefits for enterprises, achieve¥‍σ social benefits for clinics, ☆¶∏and contribute to the r πγelief of illnesses for the people$γ.
Previous: None
Next: None
Previous: None
Next: None

FEEDBACK

WRITE A MESSAGE TO US

Username used for comment:
Feedback
Description:

Releate News

Previous page
1

Contact Us

We have always regarded cus'∏tomer satisfaction as our≤φ♠ goal and have been highly praised by ¶<customers at home and abroad.£λ£↓

Hotlink:Anda Group     Copyright © 2 ∑∑021 ANFIDA. All  β↓rights reserved.    ♦£  京ICP證000000号        津公網安備12011002024060号      &nbs® ¥ p;Powered by www.300.cn

ANFIDA

麻花传MV在线观看的最新进展,狠狠躁日日躁夜夜躁2022麻豆,亚洲WWW啪成人一区二区麻豆,人妻夜夜爽天天爽三区麻豆AV网站,麻豆成人精品国产免费,国产成人精品三级麻豆,麻豆美女裸体AAAA片,麻豆 美女 丝袜 人妻 中文,国产麻豆剧传媒精品国产AV,无码人妻aⅴ一区二区三区麻豆,狠狠色丁香婷婷久久综合麻豆